The Latest Breaking News from Moderna

Moderna stock skidded Tuesday on a mixed update for its mRNA-based flu vaccine. The update could impact the shot's commercial timing.

Moderna stock rose Monday after European regulators granted its Merck-partnered personalized cancer vaccine a key designation.

The speed of which the Covid jab was developed has "unspooled" medical advancements

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Experts hope new vaccines will be ready by end of decade

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

It was based on 860,000 patients across the world. The post Being vaccinated halves risk of long COVID: study appeared first on Talker.

Tuberculosis surrendered the title of the world’s deadliest infectious disease after COVID-19 struck, but it reclaimed that terrible distinction last year. As with COVID, a new vaccine could go a long way to sharply curtailing the disease, which killed about 1.4 million people a year before the pandemic and increased…

Sen. Bernie Sanders, who rose to national prominence criticizing big business in general and the pharmaceutical industry in particular, claimed the spotlight Wednesday on what might at first seem a powerful new stage from which to advance his agenda: chairmanship of the Senate health committee.